BioMarin Pharmaceutical (BMRN) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free BMRN Stock Alerts $77.56 +0.59 (+0.77%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability BioMarin Pharmaceutical Short Interest DataCurrent Short Volume3,910,000 sharesPrevious Short Volume3,690,000 sharesChange Vs. Previous Month+5.96%Dollar Volume Sold Short$315.77 millionShort Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares189,880,000 sharesPercentage of Shares Shorted2.06%Today's Trading Volume3,433,447 sharesAverage Trading Volume1,970,463 sharesToday's Volume Vs. Average174% Short Selling BioMarin Pharmaceutical ? Sign up to receive the latest short interest report for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBMRN Short Interest Over TimeBMRN Days to Cover Over TimeBMRN Percentage of Float Shorted Over Time Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… BioMarin Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,910,000 shares $315.77 million +6.0%N/A2.5 $80.76 4/15/20243,690,000 shares $337.67 million +20.6%N/A2.6 $91.51 3/31/20243,060,000 shares $267.26 million +3.4%N/A2.3 $87.34 3/15/20242,960,000 shares $248.26 million -3.3%N/A2.2 $83.87 2/29/20243,060,000 shares $264.02 million -6.1%N/A2.1 $86.28 2/15/20243,260,000 shares $287.86 million +2.8%N/A2.2 $88.30 Get the Latest News and Ratings for BMRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,170,000 shares $279.21 million -7.3%N/A1.9 $88.08 1/15/20243,420,000 shares $319.19 million -7.6%N/A2 $93.33 12/31/20233,700,000 shares $356.75 million -15.5%N/A2.2 $96.42 12/15/20234,380,000 shares $425.56 million +29.6%N/A2.4 $97.16 11/30/20233,380,000 shares $307.85 million +9.7%N/A2 $91.08 11/15/20233,080,000 shares $268.14 million -6.4%N/A2 $87.06 10/31/20233,290,000 shares $267.97 million -53.2%N/A2.5 $81.45 10/15/20237,030,000 shares $606.97 million +7.5%N/A6.1 $86.34 9/30/20236,540,000 shares $578.66 million -0.5%N/A5.6 $88.48 9/15/20236,570,000 shares $579.21 million +5.1%N/A5.1 $88.16 8/31/20236,250,000 shares $571.13 million +3.1%N/A5 $91.38 8/15/20236,060,000 shares $549.46 million -2.4%N/A4.8 $90.67 7/31/20236,210,000 shares $546.05 million -6.3%N/A5 $87.93 7/15/20236,630,000 shares $569.32 million +51.4%N/A5.3 $85.87 6/30/20234,380,000 shares $379.66 million -27.0%N/A3.6 $86.68 6/15/20236,000,000 shares $575.04 million -10.9%N/A5.7 $95.84 5/31/20236,730,000 shares $585.11 million -3.9%N/A5.9 $86.94 5/15/20237,000,000 shares $666.26 million +4.2%N/A5.5 $95.18 4/30/20236,720,000 shares $645.39 million +4.5%N/A5.1 $96.04 4/15/20236,430,000 shares $636.63 million +8.3%3.5%4.7 $99.01 3/31/20235,940,000 shares $577.61 million -2.8%3.3%4.1 $97.24 3/15/20236,110,000 shares $536.09 million -16.1%3.4%4.1 $87.74 2/28/20237,280,000 shares $725.02 million +7.9%4.0%4.9 $99.59 2/15/20236,750,000 shares $730.22 million +3.2%3.7%4.6 $108.18 1/31/20236,540,000 shares $754.39 million -2.4%3.6%4.3 $115.35 1/15/20236,700,000 shares $755.22 million -35.3%3.7%4.3 $112.72 12/30/202210,360,000 shares $1.07 billion -1.7%5.7%6.7 $103.49 12/15/202210,540,000 shares $1.14 billion +3.2%5.8%7.2 $108.61 11/30/202210,210,000 shares $1.03 billion +4.0%5.6%7.4 $100.98 11/15/20229,820,000 shares $846.29 million -12.9%N/A7.7 $86.18 10/31/202211,270,000 shares $976.32 million -3.5%6.2%9.7 $86.63 10/15/202211,680,000 shares $1.02 billion +1.4%6.4%10.9 $87.25 9/30/202211,520,000 shares $976.55 million +0.3%6.3%11.6 $84.77 9/15/202211,490,000 shares $1.01 billion +0.6%6.3%11.5 $88.09[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. BMRN Short Interest - Frequently Asked Questions What is BioMarin Pharmaceutical's current short interest? Short interest is the volume of BioMarin Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,910,000 shares of BMRN short. Learn More on BioMarin Pharmaceutical's current short interest. What is a good short interest ratio for BioMarin Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMRN shares currently have a short interest ratio of 2.0. Learn More on BioMarin Pharmaceutical's short interest ratio. Which institutional investors are shorting BioMarin Pharmaceutical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioMarin Pharmaceutical: Walleye Trading LLC, PEAK6 Investments LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioMarin Pharmaceutical's short interest increasing or decreasing? BioMarin Pharmaceutical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,910,000 shares, an increase of 6.0% from the previous total of 3,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioMarin Pharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BioMarin Pharmaceutical: United Therapeutics Co. (9.42%), Alnylam Pharmaceuticals, Inc. (2.08%), Ionis Pharmaceuticals, Inc. (6.53%), Madrigal Pharmaceuticals, Inc. (18.68%), Alkermes plc (7.62%), BeiGene, Ltd. (1.93%), Viatris Inc. (3.84%), Sarepta Therapeutics, Inc. (6.02%), Dr. Reddy's Laboratories Limited (0.52%), Teva Pharmaceutical Industries Limited (1.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short BioMarin Pharmaceutical stock? Short selling BMRN is an investing strategy that aims to generate trading profit from BioMarin Pharmaceutical as its price is falling. BMRN shares are trading up $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioMarin Pharmaceutical? A short squeeze for BioMarin Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMRN, which in turn drives the price of the stock up even further. How often is BioMarin Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMRN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: UTHR Short Interest ALNY Short Interest IONS Short Interest MDGL Short Interest ALKS Short Interest BGNE Short Interest VTRS Short Interest SRPT Short Interest RDY Short Interest TEVA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BMRN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsNext President (Not Trump. Not Biden.)The Freeport Society4 Cryptos BETTER than BitcoinTrue Market Insiders